Aktis Oncology, INC. (AKTS) — S-1 Filings
All S-1 filings from Aktis Oncology, INC.. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (1)
-
Aktis Oncology Eyes IPO to Advance Radiopharmaceutical Pipeline
— Dec 19, 2025 Risk: high
Aktis Oncology, Inc. (AKTS) is a clinical-stage oncology company focused on expanding targeted radiopharmaceuticals to broader patient populations. The company'
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX